SBC
SBC Medical Group Holdings Inc
Next earnings Aug 11, 2026 · consensus $0.12 EPS, $45.9M rev
Last earnings -7.7% on 2026-05-14
$3.30
▲ +3.77%$3.30▼ -28.88%
over 1Y
L $2.87EODHDH $5.65
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.8%
1W+3.8%
1M+6.5%
3M-16.7%
YTD-23.8%
1Y-28.9%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy
Strong net margin (29.4%); but revenue fell -15.5% YoY.
Revenue (FY2025) $174M · FY2025
The read
Middling fundamentals offset by an attractive price (~49% below fair value) — worth a look on the value angle.
SBC Medical Group Holdings Inc shows $174M in FY2025 revenue (-15.5% YoY), a 29.4% net margin, and 20.5% ROE.
Financials · annual, by fiscal year
| Line item | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | $194M | $205M | $174M |
| Gross profit | $137M | $156M | $127M |
| Operating income | $70.7M | $70.3M | $67.5M |
| Net income | $39.4M | $46.6M | $51.0M |
| Diluted EPS | $0.42 | $0.48 | $0.50 |
| Net margin | 20.3% | 22.7% | 29.4% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$218M
EV / EBITDA3.1
EV / Sales1.3
EV / FCF9.4
P / FCF14.5
PEG (trailing)0.70
Earnings yield15.1%
FCF yield6.9%
Quality & risk
ROIC (est.)18.3%
Free cash flow$23.3M
Total debt$43.1M
Net cash$121M
Altman Z-Score4.20 safe
Piotroski F-Score4/9
Capital returns
Buyback yield1.5%
Dividend yield (est.)—
Shareholder yield1.5%
Shares Δ YoY-1.0%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRed flag in recent filings — restated periodic report (2026-04-30). Worth a closer look.
Recent filings
all on EDGAR ↗ARSPeriod ending 2025-12-312026-05-28open ↗DEFA14AFiling2026-05-28open ↗DEF 14APeriod ending 2026-05-282026-05-28open ↗8-KPeriod ending 2026-05-142026-05-20open ↗PRE 14APeriod ending 2026-05-152026-05-15open ↗10-QPeriod ending 2026-03-312026-05-14open ↗8-KPeriod ending 2026-05-142026-05-14open ↗10-K/APeriod ending 2025-12-312026-04-30open ↗4Period ending 2026-04-282026-04-29open ↗4Period ending 2026-04-212026-04-23open ↗8-KPeriod ending 2026-04-192026-04-23open ↗SCHEDULE 13D/AFiling2026-04-21open ↗
Frequently asked
- Is SBC Medical Group Holdings Inc (SBC) a buy?
- SBC currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Strong net margin (29.4%); but revenue fell -15.5% YoY.
- What is SBC's fair value?
- A Modified-Graham model based on SBC's SEC fundamentals estimates a fair value of about $4.91. It is an estimate from reported earnings, not a price target.
- Is SBC overvalued or undervalued?
- Against a Modified-Graham fair-value estimate, SBC currently appears undervalued relative to its SEC-grounded earnings power.
- What is SBC Medical Group Holdings Inc's quality score?
- SBC scores 77.78431372549018/100 (grade B+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001930313, latest 10-Q filed 2026-05-14) · EODHD · as of 6/26/2026, 7:59:49 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.